Wellington Management Group LLP Atea Pharmaceuticals, Inc. Transaction History

Wellington Management Group LLP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$2.93 - $3.82 $8,945 - $11,662	-3,053 Reduced 1.38%	218,509 $732,000
Q3 2024 Nov 14, 2024	SELL	$3.17 - $4.02 $106,524 - $135,088	-33,604 Reduced 13.17%	221,562 $742,000
Q2 2024 Aug 13, 2024	SELL	$3.31 - $4.04 $313,913 - $383,145	-94,838 Reduced 27.1%	255,166 $844,000
Q1 2024 May 15, 2024	BUY	$3.09 - $4.56 $1.08 Million - $1.6 Million	350,004 New	350,004 $1.41 Million
Q1 2023 May 12, 2023	SELL	$3.0 - $4.97 $34,521 - $57,189	-11,507 Reduced 3.86%	286,233 $958,000
Q4 2022 Feb 13, 2023	BUY	$4.35 - $6.17 $303,521 - $430,511	69,775 Added 30.61%	297,740 $1.43 Million
Q3 2022 Nov 14, 2022	BUY	$5.49 - $8.79 $767,249 - $1.23 Million	139,754 Added 158.43%	227,965 $1.3 Million
Q2 2022 Aug 15, 2022	SELL	$5.33 - $8.18 $692 - $1,063	-130 Reduced 0.15%	88,211 $626,000
Q1 2022 May 16, 2022	BUY	$5.5 - $9.19 $94,792 - $158,389	17,235 Added 24.24%	88,341 $637,000
Q4 2021 Feb 11, 2022	BUY	$7.67 - $44.59 $388,991 - $2.26 Million	50,716 Added 248.73%	71,106 $635,000
Q3 2021 Nov 15, 2021	SELL	$21.33 - $35.06 $10 Million - $16.4 Million	-468,955 Reduced 95.83%	20,390 $715,000
Q2 2021 Aug 16, 2021	BUY	$19.22 - $59.08 $8.59 Million - $26.4 Million	446,979 Added 1055.04%	489,345 $10.5 Million
Q1 2021 May 17, 2021	SELL	$41.42 - $88.44 $14,455 - $30,865	-349 Reduced 0.82%	42,366 $2.62 Million
Q4 2020 Feb 12, 2021	BUY	$26.36 - $41.78 $1.13 Million - $1.78 Million	42,715 New	42,715 $1.78 Million

112

50.9M

7.6K

38.7K

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $268M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.